HCP Live

Is there an increase of blood pressure during intravitreal injections?

Mar 21, 2019

Doug Katsev, MD

Check out the latest from the Medical News Minute

Watch Doug Katsev, MD, discuss the latest findings from JAMA Ophthalmology regarding blood pressure and intravitreal injections.

Related Videos

Jay Barth, MD

Jennifer Lim, MD, FARVO

J. Peter Campbell, MD, MPH

Related Content

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Study: Experimental drug inhibits or prevents diabetic eye disease

Managing a changing landscape of IRD pediatric cases

Curative Biotechnology files patent on ophthalmic formulation

New approach to foveal holes: Light, sound, and nutraceuticals

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Study: Experimental drug inhibits or prevents diabetic eye disease

Managing a changing landscape of IRD pediatric cases

Curative Biotechnology files patent on ophthalmic formulation

New approach to foveal holes: Light, sound, and nutraceuticals

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Study: Experimental drug inhibits or prevents diabetic eye disease

Managing a changing landscape of IRD pediatric cases

Curative Biotechnology files patent on ophthalmic formulation

New approach to foveal holes: Light, sound, and nutraceuticals

Related Content

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

Nacuity Pharmaceuticals achieves target enrollment for Phase 1/2 clinical trial of NPI-001 for treatment of retinitis pigmentosa associated with Usher syndrome

ROP: Treating and preventing blindness in preterm babies

ROP: Treating and preventing blindness in preterm babies

Study: Experimental drug inhibits or prevents diabetic eye disease

Study: Experimental drug inhibits or prevents diabetic eye disease

Managing a changing landscape of IRD pediatric cases

Managing a changing landscape of IRD pediatric cases

Curative Biotechnology files patent on ophthalmic formulation

Curative Biotechnology files patent on ophthalmic formulation

New approach to foveal holes: Light, sound, and nutraceuticals

New approach to foveal holes: Light, sound, and nutraceuticals

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.